Katharine Esselen MD MBA
Gynecologic Oncology
Gynecologic Oncologist, Assistant Professor, Harvard Medical School
Join to View Full Profile
Beth Israel Deaconess Hospital330 Brookline AveBoston, MA 02215
Phone+1 617-667-4040
Dr. Esselen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Katharine Esselen is an experienced Obstetrics and Gynecology specialist based in Boston, MA, with a specific focus on Gynecologic Oncology. She completed her fellowship and residency in Obstetrics and Gynecology at Brigham and Women’s Hospital and is currently an instructor at Harvard Medical School at Beth Israel Deaconess Medical Center. She possesses extensive knowledge and expertise in hereditary breast/ovarian cancer, uterine carcinoma, endometrial carcinoma, fallopian tube carcinoma, and hysterectomy. Additionally, she has made notable contributions to her field, as evidenced by her various publications relating to gynecologic cancers and the financial toxicity of treatment.
Education & Training
Mass General Brigham/Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2012 - 2015- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 2008 - 2012
Tufts University School of MedicineClass of 2008
Certifications & Licensure
MA State Medical License 2012 - 2027
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Out-of-pocket expenses and hospital write-offs are associated with patient reported financial toxicity.Katharine M Esselen, Annika Gompers, Rasha A Baig, Nadiha Noor Chelsea, Kerry Rogers
Supportive Care in Cancer. 2025-02-25 - 1 citationsImplementation of a financial navigation program in gynecologic oncology.Nadiha Noor Chelsea, Natalie Posever, Tina Yi Jin Hsieh, Sutania Patterson, Christine Sweeney
Gynecologic Oncology. 2024-10-01 - Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer.Joseph A Dottino, Katharine M Esselen, Rebecca Costa, Stephanie Argetsinger, Mahnum Shahzad
Value in Health. 2024-09-01
Press Mentions
Financial Toxicity Impacts Nearly 50% of Women with Gynaecologic CancerJune 15th, 2021- Financial Toxicity Associated with Cancer Care Impacts Nearly 50% of Women with Gynecologic Cancer and Disproportionately AffectsJune 11th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
